Pacific Biosciences of California, Inc. (PACB) Comparison with companies in other sectors?

Pacific Biosciences of California, Inc. has a share price of 300.08M. You can analyze Pacific Biosciences of California, Inc. (PACB) competitors across different market sectors through stock heatmaps.

What are PACB's NET and operating margins?

Pacific Biosciences of California, Inc. (PACB) operating margin is around -5.19, and net profit margin is approximately -4.32 as of the latest reports.

In what way does PACB's earnings per share (EPS) trend reflect its financial momentum?

Pacific Biosciences of California, Inc. (PACB) EPS is -2.74 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Pacific Biosciences of California, Inc. is -0.56, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Pacific Biosciences of California, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Pacific Biosciences of California, Inc. like P/E which is -0.69, P/B which is 4.97, and PEG which is 0.007. Compare them with sector averages to evaluate if the stock is priced fairly.

Pacific Biosciences of California, Inc.

PACB•NASDAQ

Healthcare

Medical - Devices

$1.68

$0.14(9.35%)

Pacific Biosciences of California, Inc. (PACB) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-2.74

P/E Ratio

-0.56

ROE

-1.70%

Net Margin

-4.32%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$462.13M

Shares OutstandingTotal number of shares issued

$300.08M

Book Value/ShareNet worth per share

$0.31

Revenue/ShareAnnual revenue per share

$0.51

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-2.74

Net MarginNet income as percentage of revenue

-431.71%

Operating MarginOperating income as percentage of revenue

-519.00%

ROEReturn on shareholders' equity

-170.40%

ROAReturn on total assets

-76.41%

ROCEReturn on capital employed

-99.57%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.62

Cash/ShareCash and equivalents per share

$1.16

FCF YieldFree cash flow as percentage of market cap

-39.27%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for PACBFinancial Ratios Analysis details for PACB are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for PACBSector Benchmarking details for PACB are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Pacific Biosciences of California, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Pacific Biosciences of California, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Pacific Biosciences of California, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Pacific Biosciences of California, Inc.

For Pacific Biosciences of California, Inc., essential financial indicators include EPS -2.74, PE -0.56, and ROE -1.70. These key ratios reveal insights into Pacific Biosciences of California, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Pacific Biosciences of California, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Pacific Biosciences of California, Inc.

Metrics like Net Margin -431.71% and ROA -76.41% shed light on how well Pacific Biosciences of California, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Pacific Biosciences of California, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Pacific Biosciences of California, Inc.

Using ratios such as P/B Ratio 4.97 and PEG Ratio 0.007, investors can assess whether Pacific Biosciences of California, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Pacific Biosciences of California, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Pacific Biosciences of California, Inc.

Financial health indicators, such as Debt/Equity Ratio 7.63 and Cash Flow $-0.62, provide a snapshot of Pacific Biosciences of California, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Pacific Biosciences of California, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Pacific Biosciences of California, Inc.

Investing in Pacific Biosciences of California, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Pacific Biosciences of California, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;